Details of Drug-Drug Interaction
| Drug General Information (ID: DDIYC2JSM8) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Drug Name | Carbamoylcholine (ophthalmic) | Drug Info | Propantheline | Drug Info | |||||
| Drug Type | Small molecule | Small molecule | |||||||
| Therapeutic Class | Ophthalmic Glaucoma Agents | Antispasmodics | |||||||
| Structure | |||||||||
| Mechanism of Carbamoylcholine (ophthalmic)-Propantheline Interaction (Severity Level: Moderate) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Antagonize the effect of cholinergic agents Click to Show/Hide Mechanism Graph | |||||||||
 |
|||||||||
| Drug Name | Carbamoylcholine (ophthalmic) | Propantheline | |||||||
| Mechanism |
Cholinergic effects Muscarinic acetylcholine receptor Agonist |
Anticholinergic effects Muscarinic acetylcholine receptor Antagonist |
|||||||
| Key Mechanism Factor 1 | |||||||||
| Factor Name | Muscarinic acetylcholine receptor M | Structure Sequence | |||||||
| Protein Family | G-protein coupled receptor 1 family | ||||||||
| Protein Function |
The muscarinic acetylcholine receptor mediates various cellular responses, including inhibition of adenylate cyclase, breakdown of phosphoinositides and modulation of potassium channels through the action of G proteins. Primary transducing effect is Pi turnover.
Click to Show/Hide
|
||||||||
| Mechanism Description |
|
||||||||
| Recommended Action | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Management | Patients receiving long-term therapy with anticholinergic agents should be monitored for potentially diminished therapeutic (miotic) response to ophthalmic cholinergic therapy, and dosages adjusted as necessary. | ||||||||
| References | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Multum Information Services, Inc. Expert Review Panel. | ||||||||||||||||||
| 2 | Product Information. Pilopine HS (pilocarpine ophthalmic). Alcon Laboratories Inc, Fort Worth, TX. | ||||||||||||||||||